-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

722.O1.6 722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Biological Studies

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution Program: Oral and Poster Abstracts
Type: Oral
Monday, December 7, 2015: 6:15 PM-7:45 PM
W311EFGH, Level 3 (Orange County Convention Center)
Moderators:
Betty K. Hamilton, MD, Cleveland Clinic Taussig Cancer Institute and Attilio Olivieri, MD, Ospedali Riuniti di Ancona

Disclosures:
No relevant conflicts of interest to declare.
6:15 PM

Masahiro Hirakawa, MD, PhD1*, Tiago R Matos, MD, MSc1*, John Koreth, MBBS, DPhil1, Edouard Forcade, MD1*, Jennifer Whangbo, MD, PhD2, Kazuyuki Murase, MD, PhD1,3, Hongye Liu1*, Sarah Nikiforow, MD, PhD1, Vincent T Ho, MD4, Corey S Cutler, MD, MPH1, Philippe Armand, MD, PhD1, Edwin P. Alyea, MD1, Joseph H. Antin, MD1, Robert J. Soiffer, MD5 and Jerome Ritz, MD2

1Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
2Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA
3Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, Sapporo, Japan
4Dana-Farber Cancer Institute, Boston, MA
5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

6:30 PM

Ryan H Moy, MD, PhD1,2*, Austin P Huffman, BA2,3*, Lee P Richman, BA2*, Lisa Crisalli, BS2*, James A Hoxie, MD2*, Robert H Vonderheide, MD, DPhil2*, David L Porter, MD2 and Ran Reshef, MD3,4

1Department of Medicine, NewYork-Presbyterian Hospital-Weill Cornell Medical College, New York, NY
2Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
3Division of Hematology/Oncology and the Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, NY
4Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York

6:45 PM

Elena Buces1,2*, Carolina Martínez-Laperche1,3*, M Carmen Aguilera4*, Antoni Picornell1,3*, Rosa Lillo4*, Milagros González-Rivera3,5*, Anna Bosch-Vizcaya6*, Beatriz Martín-Antonio7*, Jose B Nieto8*, Vicent Guillem9*, Marcos González, MD, PhD10*, Rafael De la Cámara11*, Salut Brunet, MD, PhD12*, Antonio Jimenez-Velasco13*, Ildefonso Espigado, MD, PhD14, Carlos Vallejo15*, Antonia Sampol, MD, PhD16*, David Serrano1,3*, Mi Kwon, MD1,2*, Jorge Gayoso1,3*, Pascual Balsalobre, PhD1,3*, Álvaro Urbano-Izpizua7*, Carlos Solano, M.D.17, David Gallardo6*, José Luis Díez Martín18,19, Juan Romo4* and Ismael Buno1,3*

1Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
2Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
3Hospital General Universitario Gregorio Marañón, Madrid, Spain
4Department of Statistics, Universidad Carlos III de Madrid, Madrid, Spain
5Instituto de Investigación Sanitaria, Madrid, Spain
6ICO Hospital Josep Trueta, Girona, Spain
7Hospital Clínic, IDIBAPS, Barcelona, Spain
8Hospital Universitario Morales Meseguer, Murcia, Spain
9Hospital Clínico de Valencia, Valencia, Spain
10Hospital Clínico Universitario de Salamanca, Salamanca, Spain
11Hospital Universitario de La Princesa, Madrid, Spain
12Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
13Hospital Regional de Málaga, Málaga, Spain
14Hospital Universitario Virgen del Rocío, Sevilla, Sevilla, Spain
15Hospital central de Asturias, Oviedo, Spain
16Hospital Son Espases, Palma de Mallorca, Spain
17Hospital Clinico de Valenci, Valencia, Spain
18Hematology Service, Hospital Gregorio Marañón. Health Research Institute Gregorio Marañón., Madrid, Spain
19Instituto de Investigacion Sanitaria Hospital Gregorio Marañon, Madrid, Spain

7:00 PM

Frances T. Hakim, PhD1*, Sarfraz Memon, MD1*, Ping Jin, PhD2*, Matin M. Imanguli, DDS, MD1*, Najibah Rehman, MD1*, Xiao-Yi Yan, MS1*, Jeremy J. Rose, BA1*, Jacqueline W. Mays, DDS, PhD3*, Susan Dhamala, BA1*, Veena Kapoor1*, William Telford, PhD1*, David C. Halverson, MD1*, Kristin Baird, MD4,5*, Daniel H. Fowler, MD1*, David Stroncek, MD6, Edward W. Cowen, MD, MHSc7*, Steven Z. Pavletic, MD1 and Ronald E. Gress, MD1

1Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD
2Department of Transfusion Medicine, National Institutes of Health, Clinical Center, Bethesda, MD
3Clinical Research Core, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD
4Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD
5Center For Biologics Evaluation and Research, FDA, Rockville, MD
6Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD
7Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD

7:15 PM

Takanori Yoshioka, MD1*, Yusuke Meguri, MD1*, Takeru Asano, MD1*, Yuriko Kishi1*, Miki Iwamoto1*, Yoshinobu Maeda, MD, PhD1, Mitsune Tanimoto, MD, PhD1 and Ken-Ichi Matsuoka, MD, PhD2*

1Department of Hematology and Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
2Hematology and Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

7:30 PM

Edouard Forcade, MD1,2*, Haesook T. Kim, PhD3,4*, Corey S Cutler, MD, MPH1,2, Kathy S. Wang, PhD1,2, Vincent T Ho, MD2,5, John Koreth, MBBS, DPhil1,2, Philippe Armand, MD, PhD1,2, Edwin P. Alyea, MD2,6, Bruce R. Blazar, MD7, Robert J. Soiffer, MD2,5, Joseph H. Antin, MD1,2 and Jerome Ritz, MD2,8

1Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
2Harvard Medical School, Boston, MA
3Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
4Harvard School of Public Health, Boston
5Dana-Farber Cancer Institute, Boston, MA
6Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
7Division of Pediatrics, Department of Medicine, University of Minnesota Cancer Center, Minneapolis, MN
8Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA

*signifies non-member of ASH